Acessibilidade / Reportar erro

Pressure and time dependence of the cardiopulmonary reflex response in patients with hypertensive cardiomyopathy

Abstract

The first minutes of the time course of cardiopulmonary reflex control evoked by lower body negative pressure (LBNP) in patients with hypertensive cardiomyopathy have not been investigated in detail. We studied 15 hypertensive patients with left ventricular dysfunction (LVD) and 15 matched normal controls to observe the time course response of the forearm vascular resistance (FVR) during 3 min of LBNP at -10, -15, and -40 mmHg in unloading the cardiopulmonary receptors. Analysis of the average of 3-min intervals of FVR showed a blunted response of the LVD patients at -10 mmHg (P = 0.03), but a similar response in both groups at -15 and -40 mmHg. However, using a minute-to-minute analysis of the FVR at -15 and -40 mmHg, we observed a similar response in both groups at the 1st min, but a marked decrease of FVR in the LVD group at the 3rd min of LBNP at -15 mmHg (P = 0.017), and -40 mmHg (P = 0.004). Plasma norepinephrine levels were analyzed as another neurohumoral measurement of cardiopulmonary receptor response to LBNP, and showed a blunted response in the LVD group at -10 (P = 0.013), -15 (P = 0.032) and -40 mmHg (P = 0.004). We concluded that the cardiopulmonary reflex response in patients with hypertensive cardiomyopathy is blunted at lower levels of LBNP. However, at higher levels, the cardiopulmonary reflex has a normal initial response that decreases progressively with time. As a consequence of the time-dependent response, the cardiopulmonary reflex response should be measured over small intervals of time in clinical studies.

Baroreflex; Essential hypertension; Heart failure; Cardiopulmonary reflex; Baroreceptors


Braz J Med Biol Res, November 2004, Volume 37(11) 1615-1622

Pressure and time dependence of the cardiopulmonary reflex response in patients with hypertensive cardiomyopathy

M.E.B. Otto, F.M. Consolim-Colombo, C.R.M. Rodrigues Sobrinho and E.M. Krieger

Unidade de Hipertensão, Instituto do Coração, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil

References

Correspondence and Footnotes Correspondence and Footnotes Correspondence and Footnotes

Abstract

The first minutes of the time course of cardiopulmonary reflex control evoked by lower body negative pressure (LBNP) in patients with hypertensive cardiomyopathy have not been investigated in detail. We studied 15 hypertensive patients with left ventricular dysfunction (LVD) and 15 matched normal controls to observe the time course response of the forearm vascular resistance (FVR) during 3 min of LBNP at -10, -15, and -40 mmHg in unloading the cardiopulmonary receptors. Analysis of the average of 3-min intervals of FVR showed a blunted response of the LVD patients at -10 mmHg (P = 0.03), but a similar response in both groups at -15 and -40 mmHg. However, using a minute-to-minute analysis of the FVR at -15 and -40 mmHg, we observed a similar response in both groups at the 1st min, but a marked decrease of FVR in the LVD group at the 3rd min of LBNP at -15 mmHg (P = 0.017), and -40 mmHg (P = 0.004). Plasma norepinephrine levels were analyzed as another neurohumoral measurement of cardiopulmonary receptor response to LBNP, and showed a blunted response in the LVD group at -10 (P = 0.013), -15 (P = 0.032) and -40 mmHg (P = 0.004). We concluded that the cardiopulmonary reflex response in patients with hypertensive cardiomyopathy is blunted at lower levels of LBNP. However, at higher levels, the cardiopulmonary reflex has a normal initial response that decreases progressively with time. As a consequence of the time-dependent response, the cardiopulmonary reflex response should be measured over small intervals of time in clinical studies.

Key words: Baroreflex, Essential hypertension, Heart failure, Cardiopulmonary reflex, Baroreceptors

Introduction

Hypertension is considered to be a major health problem, with clear evidence that it is one of the most important causes of heart failure (1). Indeed, heart failure (2-7) and hypertension (8-13) are associated with abnormalities in cardiovascular reflexes and neurohumoral regulation, each of which are independent risk factors for increased cardiovascular morbidity and mortality (14-19).

Studies on animals and humans have shown that both the cardiopulmonary and the arterial baroreflex play important roles in regulating the cardiovascular system (20-24). Clear evidence exists that the cardiopulmonary reflex control is impaired in humans with severe left ventricular dysfunction (LVD, 2,5-7) and hypertension (9,10,25,26). However, most studies of cardiopulmonary reflex control in humans have used data averaged over several minutes, without including the 1st min of progressive levels of lower body negative pressure (LBNP) to analyze the nature of this impairment in patients with hypertension (9,10,25) and LVD (5,7). We are not aware of studies that analyzed the cardiopulmonary reflex minute-to-minute, including the 1st min of stimulation, which could be an important parameter to understand the mechanism of reflex impairment because the neural reflex response is very rapid at its onset. Therefore, the analysis of the average of several minutes might mask transient changes.

More recently, Hisdal et al. (27) observed transient changes in cardiovascular variables after the rapid onset and release of low levels of LBNP in normal volunteers, which clearly demonstrates that the intensity and time of stimulus application are important to the activation of the different receptors. Furthermore, the reflex response is very rapid at its onset, and when the overall response is analyzed as an average over several minutes, transient changes in the reflex response cannot be detected.

Our objective was to determine in patients with hypertensive cardiomyopathy whether minute-to-minute analysis of the forearm vascular resistance (FVR) in comparison with averaging over several minutes, as reported by many studies, is able to detect differences in the time course of the cardiopulmonary reflex and to provide information about the mechanism of the reflex.

Subjects and Methods

Subjects

The study included 15 patients (8 men and 7 women), 35 to 59 years of age, mean body mass index 27.3 ± 2.5 kg/m2, with mild-to-moderate LVD determined by calculation of the ejection fraction by echocardiography using Simpson's method (group with LVD). The ejection fractions ranged from 36 to 50%, and the mean left ventricle diameter was 63 ± 2.3 mm. All patients were asymptomatic at rest and during exercise and none showed evidence of lung congestion on the day of the study. The LVD group was compared to 15 healthy controls (7 men and 8 women), mean body mass index 26.5 ± 2.0 kg/m2, 31 to 58 years of age (normal control group). All subjects had normal laboratory tests that included a complete blood count as well as blood glucose, blood urea nitrogen, and serum creatinine levels. Total cholesterol levels (normal = 203 ± 7 vs LVD = 197 ± 11, P = NS) and triglyceride levels (normal = 106 ± 8 vs LVD = 107 ± 8, P = NS) were also similar in both groups. None of the patients were diabetic, had any other associated disease or used any medications, including hormonal therapy for the women in both groups. Written consent was obtained from all subjects before the study, and the Medical Ethics Committee of the University of São Paulo Medical School, São Paulo, Brazil, approved the study protocol.

Hemodynamic measurements

The following hemodynamic measurements were performed: arterial blood pressure, heart rate, central venous pressure (CVP), forearm blood flow (FBF), and FVR. All measurements were recorded simultaneously on a Gould strip-chart recorder (RS 3800; Gould Inc., Recording System Division, Valley View, OH, USA) and on a computer (Gateway 2000 4DX2-66V) with a CODAS system for data analysis (Computer Operated Data Acquisition Software: AT-CODAS; DATAQ Instruments, Inc., Akron, OH, USA).

Arterial blood pressure was measured with a digital photoplethysmograph, which provides accurate beat-to-beat systolic and diastolic values in mmHg (Finapress, Omeda 2300, Monitoring Systems, Englewood, CO, USA). Heart rate was calculated by analysis of the peak systolic interval of the arterial pressure curves obtained with the digital photoplethysmograph. CVP (mmHg) was obtained with a polyethylene catheter (Intracath, 16 gauge/24"; Jonhson & Jonhson, Waterloo, Belgium) inserted percutaneously through an antecubital vein into the left arm and advanced to the right atrium under fluoroscopy in the Hemodynamic Laboratory. This device was connected to a Gould P23 transducer in the Hypertension Laboratory, and the CVP values were determined; the zero reference was estimated at the subjects' midaxillary level in the fourth intercostal space. FBF (ml/100 ml forearm volume per minute) was measured in the right arm by venous occlusion plethysmography using a double-stranded mercury-in-silastic strain gauge designed by Whitney (28). The venous occlusion pressure was 35 to 40 mmHg. The circulation in the hand was blocked by inflating a wrist cuff above the systolic pressure for 1 min before limb blood flow was determined. Venous occlusion was performed every 10 s and 3 curves of FBF per min at baseline and increasing levels of LBNP were determined. The average was then calculated as the mean value of data collected during 1 min of each stimulus. FVR (units) was calculated as mean arterial pressure/FBF.

Humoral measurements

Humoral measurements consisted of determining norepinephrine concentration in blood samples withdrawn from the right atrium at the end of the baseline period and at each level of LBNP. Blood was stored in pre-chilled tubes and processed at low temperatures by high performance liquid chromatography.

Protocol

Hypertensive patients had their medication regimens changed with the progressive withdrawal of beta-blockers, angiotensing convertig enzyme inhibitors and central alpha-blockers over a 3-week period. During the last week before the experiment, they received only vasodilators with short half-lives (nifedipine or hydralazine) and loop diuretics (furosemide). Administration of these medications was discontinued 24 h before the study. Patients did not consume alcohol or caffeine 24 h before the protocol, and no smokers were included in the study.

The experimental protocol was similar to that used in a previous study performed in our laboratory (29). Hemodynamic variables were continuously measured during the 3-min baseline period and during sequential applications of LBNP at -10, -15, and -40 mmHg, with a 5-min rest between stimuli. Each LBNP stimulus was preceded by 1 min of baseline measurements to confirm that these parameters were stable.

Statistical analysis

Data were processed with JMP 5.0 software (a business unit from the SAS Institute). Baseline values, the average of 3 min of each stimulus, and the norepinephrine response were compared between groups by the unpaired Student t-test. Analysis of variance for repeated measures was used to compare the minute-to-minute responses of the FVR during the 3 min of LBNP at -10, -15 and -40 mmHg. P values of <0.05 were considered to be significant. Data are reported as means ± SEM.

Results

Baseline hemodynamic data

Systolic, diastolic and mean blood pressures and heart rate were significantly higher in the LVD group (Table 1). The CVP, FBF, and FVR were similar in both groups

(Table 1).

Hemodynamic responses to LBNP: analysis of the 3-min average data

LBNP at -10 mmHg. In response to -10 mmHg of LBNP, both groups showed a similar decrease in CVP (Table 2). Systolic, diastolic, mean blood pressures, and heart rate did not change significantly compared to baseline values (Table 2). In the normal group, FBF decreased and FVR increased significantly from baseline (Table 3). The decrease in FBF variation and the percent increase in FVR variation were markedly reduced in the LVD group (Table 3).

LBNP at -15 and -40 mmHg. The decrease in CVP was similar in both groups at -15 and -40 mmHg of LBNP (Table 2). Systolic, diastolic, and mean blood pressures did not change significantly from baseline values in either group (Table 2). However, heart rate increased significantly from baseline in both groups at -40 mmHg of LBNP (Table 2). The percent variation in FBF decrease and FVR increase did not differ significantly from baseline for either group (Table 3).

Hemodynamic responses to LBNP: analysis of the 1-min average data

Minute-to-minute FVR analysis showed that the LVD group has a blunted response during all 3 min at -10 mmHg of LBNP without differences between minutes (Figure 1). Conversely, at -15 and -40 mmHg of LBNP, the LVD group had a normal response in the 1st min, but a marked decrease in FVR up to the 3rd min of each stimulus (Figure 1).

Hormonal responses to LBNP

Plasma norepinephrine responses to LBNP at -10, -15, and -40 mmHg were measured in 13 patients of the LVD group and 9 patients of the normal group. There was a trend to higher baseline plasma levels of norepinephrine (in pg/ml) in the LVD group (LVD: 342.6 ± 43.5 vs normal: 245.0 ± 23.2; P = 0.06). Percent variations in plasma norepinephrine during LBNP were attenuated in the LVD group at -10 mmHg (LVD: 7 ± 6 vs normal: 38 ± 9%, P = 0.013), -15 mmHg (LVD: 35 ± 6 vs normal: 54 ± 11%, P = 0.032), and -40 mmHg (LVD: 40 ± 7 vs normal: 104 ± 13%, P = 0.004).

Figure 1.
Minute-to-minute changes in forearm vascular resistance during the first 3 min at -10, -15 and -40 mmHg of lower body negative pressure. Each minute was compared to data presented in Table 1. FVR = forearm vascular resistance; LBNP = lower body negative pressure; LVD = left ventricular dysfunction group; NL = normal group. +P < 0.05 compared to NL; *P < 0.05 compared to previous minutes (analysis of variance for repeated measures).

Table 1.
Baseline hemodynamic data of normotensive controls and hypertensive patients with left ventricular dysfunction.

Table 2.
Absolute changes in cardiovascular variables during lower body negative pressure.

Table 3.
Three-minute interval average measurements of variations in forearm vascular resistance and forearm blood flow during lower body negative pressure.

Discussion

The most important finding of this study was the accurate minute-by-minute characterization of the time course of the cardiopulmonary reflex control during 3 min of LBNP in hypertensive cardiomyopathy. Important information was lost when the analysis averaged 3-min data. In contrast to previous studies, by using a minute-to-minute analysis of FVR we observed a sustained blunted response in the LVD group during 3 min of LBNP at -10 mmHg, but a normal initial response at the 1st min of -15 and -40 mmHg of LBNP, with a marked decrease up to the 3rd min for each stimulus.

The present study is the first to characterize the temporal behavior of the cardiopulmonary reflex response in patients with hypertensive cardiomyopathy using a minute-to-minute analysis. We included data for the 1st min of the stimulus, in contrast to the studies which used the average of several minutes and which did not include the 1st min of LBNP (8-10).

Normal volunteers submitted to rapid low levels of LBNP showed a decrease in mean arterial blood pressure during the first seconds of receptor unloading (27). These premature hemodynamic alterations caused by LBNP may cause an early deactivation of the cardiopulmonary reflex. The present data revealed the importance of minute-to-minute analysis of the response from the 1st min for a better characterization of the physiology and pathophysiology of the cardiopulmonary reflex regulation. In the present data, unlike the minute-to-minute analysis of FVR, the analysis of the average of 3 min failed to show the impairment of the reflex response indicated by a blunted norepinephrine response at -15 and -40 mmHg of LBNP in the LVD group.

The similar decrease in CVP observed during the application of increasing levels of LBNP indicates an equivalent receptor unloading in both groups. Changes in FVR were observed without significant changes in arterial blood pressure or heart rate during -10 mmHg of LBNP, suggesting that the vascular responses were mainly due to the cardiopulmonary reflex. During -40 mmHg of LBNP, the small increase in heart rate indicated that the arterial baroreceptors, in addition to the cardiopulmonary baroreceptors, were unloaded, in agreement with previous reports that the application of LBNP higher than -20 mmHg also engages arterial baroreceptors in the final response (23,30). Nevertheless, this small increase does not exclude the participation of the arterial baroreceptors in the hemodynamic responses induced even by low levels of LBNP, such as -15 mmHg (23,30).

The impaired norepinephrine responses to LBNP in the LVD group constitute additional evidence for an altered cardiopulmonary reflex response. Similar findings of an impaired norepinephrine response to LBNP were obtained in patients with LVD (5) and hypertension (10,25).

The minute-to-minute analyses of FVR at -10, -15 and -40 mmHg of LBNP were able to demonstrate a different pattern of response in the LVD group. There was a parallel, but blunted response of FVR in the LVD group compared to control at lower levels of LBNP (-10 mmHg), when the reflex response is mainly a consequence of cardiopulmonary receptor unloading. However, at higher levels of LBNP (-15 and -40 mmHg), when the arterial baroreceptors in addition to the cardiopulmonary receptors are participating in the reflex response, the LVD group had an increase in FVR similar to the control group in the 1st min, but a significant decrease over 3 min. In contrast, the control group showed a small change in the reflex response along minutes, probably as a consequence of normal interaction of the two reflexes and a normal sympathetic activation response.

The mechanisms associated with impairment of the cardiopulmonary reflex and baroreflex sensitivity (2,31-33) in patients with LVD and hypertension are not clear. To understand the mechanism underlying the present findings, we speculate that at higher levels of LBNP, the unloading of arterial baroreceptors could initially compensate the impairment of the cardiopulmonary reflex resulting in the initial normal response. However, as a consequence of the limitations of the methodology of reflex analysis applied to humans, it is not possible to precisely separate the responses of cardiopulmonary receptors and baroreceptors and the exact time of their initial influence on the final response. In addition, the impaired response observed in hypertensive patients with left ventricle dysfunction might be also the consequence of alterations in the neurohumoral regulation of other substances, such as atrial natriuretic peptide and renin, each of which is also regulated by the cardiopulmonary reflex (34,35).

There is clear evidence that LBNP is a good test for orthostatic tolerance (36), and that the cardiopulmonary response is attenuated in these patients. Especially considering the characteristics of progressive deterioration, the prevalence of orthostatic intolerance in these patients could be increased. Therefore, frequently used medications to treat hypertension and LVD, such as vasodilators and diuretics, should be prescribed with caution to patients whose cardiopulmonary reflex is impaired.

The present data agree with previous reports that the cardiopulmonary reflex and plasma norepinephrine responses are impaired in patients with hypertensive cardiomyopathy. However, the present results characterize the time course of the progressive impairment of the reflex response during periods of LBNP and the normal initial response at higher levels of LBNP, showing the importance to monitor the time-course of the FVR response from the 1st min of stimulation and at subsequent 1-min intervals.

Address for correspondence: M.E.B. Otto, Unidade de Hipertensão, InCor, Faculdade de Medicina, USP, Av. Dr. Eneas C. Aguiar, 44, 05403-000, São Paulo, SP, Brasil. Fax: +55-11-3069-5048. E-mail: maria.otto@zerbini.org.br

Research supported by the E. Zerbini Foundation and FAPESP (No. 01/00009-0). Received May 11, 2004. Accepted September 3, 2004.

  • 1. Vasan RS & Levy D (1996). The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview. Archives of Internal Medicine, 156: 1789-1796.
  • 2. Zucker IH, Schultz HD, Li YF, Wang Y, Wang W & Patel KP (2004). The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide. Progress in Biophysics and Molecular Biology, 84: 217-232.
  • 3. Zucker IH, Wang W, Brandle M, Schultz HD & Patel KP (1995). Neural regulation of sympathetic nerve activity in heart failure. Progress in Cardiovascular Diseases, 37: 397-414.
  • 4. Packer M (1992). The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. Journal of the American College of Cardiology, 20: 248-254.
  • 5. Mohanty PK, Arrowood JA, Ellenbogen KA & Thames MD (1989). Neurohumoral and hemodynamic effects of lower body negative pressure in patients with congestive heart failure. American Heart Journal, 118: 78-85.
  • 6. Modesti PA, Polidori G, Bertolozzi I, Vanni S & Cecioni I (2004). Impairment of cardiopulmonary receptor sensitivity in the early phase of heart failure. Heart, 90: 30-36.
  • 7. Ferguson DW, Abboud FM & Mark AL (1984). Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation, 69: 451-460.
  • 8. Trimarco B, De Luca N, Ricciardelli B, Cuocolo A, Rosiello G, Lembo G & Volpe M (1986). Effects of lower body negative pressure in hypertensive patients with left ventricular hypertrophy. Journal of Hypertension, 4 (Suppl): S306-S309.
  • 9. Trimarco B, De Luca N, Ricciardelli B, Cuocolo A, De Simone A, Volpe M, Mele AF & Condorelli M (1986). Impaired responsiveness of the ventricular sensory receptor in hypertensive patients with left ventricular hypertrophy. Circulation, 74: 980-990.
  • 10. Grassi G, Giannattasio C, Cleroux J, Cuspidi C, Sampieri L, Bolla GB & Mancia G (1988). Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension. Hypertension, 12: 227-237.
  • 11. Mancia G, Grassi G & Giannattasio C (1988). Cardiopulmonary receptor reflex in hypertension. American Journal of Hypertension, 1: 249-255.
  • 12. Grassi G, Giannattasio C, Seravalle G, Cattaneo BM, Cleroux J & Mancia G (1990). Cardiogenic reflexes and left ventricular hypertrophy. European Heart Journal, 11 (Suppl G): 95-99.
  • 13. Zanchetti A & Mancia G (1991). Cardiovascular reflexes and hypertension. Hypertension, 18: III-13-III-21.
  • 14. Moe GW, Rouleau JL, Charbonneau L, Proulx G, Arnold JM, Hall C, de Champlain J, Barr A, Sirois P & Packer M (2000). Neurohormonal activation in severe heart failure: relations to patient death and the effect of treatment with flosequinan. American Heart Journal, 139: 587-595.
  • 15. Cohn JN (1995). Plasma norepinephrine and mortality. Clinical Cardiology, 18: I-9-I-12.
  • 16. Omland T, Aarsland T, Aakvaag A, Lie RT & Dickstein K (1993). Prognostic value of plasma atrial natriuretic factor, norepinephrine and epinephrine in acute myocardial infarction. American Journal of Cardiology, 72: 255-259.
  • 17. Packer M, Lee WH, Kessler PD, Gottlieb SS, Bernstein JL & Kukin ML (1987). Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation, 75: IV-80-IV-92.
  • 18. Hirsch AT, Dzau VJ & Creager MA (1987). Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistance. Circulation, 75: IV-36-IV-48.
  • 19. Chobanian AV, Bakris GL, Black HR et al. (2003). Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42: 1206-1252.
  • 20. Thoren P (1979). Role of cardiac vagal C-fibers in cardiovascular control. Reviews of Physiology, Biochemistry and Pharmacology, 86: 1-94.
  • 21. Salgado HC & Krieger EM (1981). Baroreceptor resetting during pressure recovery from hypotension. Hypertension, 3: II-147-II-150.
  • 22. Krieger EM, Salgado HC & Michelini LC (1982). Resetting of the baroreceptors. International Review of Physiology, 26: 119-146.
  • 23. Johnson JM, Rowell LB, Niederberger M & Eisman MM (1974). Human splanchnic and forearm vasoconstrictor responses to reductions of right atrial and aortic pressures. Circulation Research, 34: 515-524.
  • 24. Grassi G, Giannattasio C, Cuspidi C, Bolla GB, Cleroux J, Ferrazzi P, Fiocchi R & Mancia G (1988). Cardiopulmonary receptor regulation of renin release. American Journal of Medicine, 84: 97-104.
  • 25. Trimarco B, Lembo G, De Luca N, Volpe M, Ricciardelli B, Condorelli G, Rosiello G & Condorelli M (1989). Blunted sympathetic response to cardiopulmonary receptor unloading in hypertensive patients with left ventricular hypertrophy. A possible compensatory role of atrial natriuretic factor. Circulation, 80: 883-892.
  • 26. Uggere TA, Abreu GR, Sampaio KN, Cabral AM & Bissoli NS (2000). The cardiopulmonary reflexes of spontaneously hypertensive rats are normalized after regression of left ventricular hypertrophy and hypertension. Brazilian Journal of Medical and Biological Research, 33: 589-594.
  • 27. Hisdal J, Toska K & Walloe L (2001). Beat-to-beat cardiovascular responses to rapid, low-level LBNP in humans. American Journal of Physiology, 281: R213-R221.
  • 28. Whitney RJ (1953). The measurement of volume changes in human limbs. Journal of Physiology, 121: 1-27.
  • 29. Consolim-Colombo FM, Filho JA, Lopes HF, Sobrinho CR, Otto ME, Riccio GM, Mady C & Krieger EM (2000). Decreased cardiopulmonary baroreflex sensitivity in Chagas' heart disease. Hypertension, 36: 1035-1039.
  • 30. Pannier B, Slama MA, London GM, Safar ME & Cuche JL (1995). Carotid arterial hemodynamics in response to LBNP in normal subjects: methodological aspects. Journal of Applied Physiology, 79: 1546-1555.
  • 31. Zucker IH, Wang W & Schultz HD (1995). Cardiac receptor activity in heart failure: implications for the control of sympathetic nervous outflow. Advances in Experimental Medicine and Biology, 381: 109-124.
  • 32. Ferguson DW, Berg WJ, Roach PJ, Oren RM & Mark AL (1992). Effects of heart failure on baroreflex control of sympathetic neural activity. American Journal of Cardiology, 69: 523-531.
  • 33. Dibner-Dunlap M (1992). Arterial or cardiopulmonary baroreflex control of sympathetic nerve activity in heart failure. American Journal of Cardiology, 70: 1640-1642.
  • 34. Thomas CJ & Woods RL (2003). Guanylyl cyclase receptors mediate cardiopulmonary vagal reflex actions of ANP. Hypertension, 41: 279-285.
  • 35. Egan B, Fitzpatrick MA & Julius S (1987). The heart and the regulation of renin. Circulation, 75: I-130-I-133.
  • 36. Hyatt KH, Jacobson LB & Schneider VS (1975). Comparison of 70 degrees tilt, LBNP, and passive standing as measures of orthostatic tolerance. Aviation Space and Environmental Medicine, 46: 801-808.
  • Correspondence and Footnotes

  • Publication Dates

    • Publication in this collection
      26 Oct 2004
    • Date of issue
      Nov 2004

    History

    • Accepted
      03 Sept 2004
    • Received
      11 May 2004
    Associação Brasileira de Divulgação Científica Av. Bandeirantes, 3900, 14049-900 Ribeirão Preto SP Brazil, Tel. / Fax: +55 16 3315-9120 - Ribeirão Preto - SP - Brazil
    E-mail: bjournal@terra.com.br